---
figid: PMC5356579__oncotarget-07-68638-g002
figtitle: Somatic POLE P286R mutation defines a unique subclass of colorectal cancer
  featuring hypermutation, representing a potential genomic biomarker for immunotherapy
organisms:
- NA
pmcid: PMC5356579
filename: oncotarget-07-68638-g002.jpg
figlink: /pmc/articles/PMC5356579/figure/F2/
number: F2
caption: 'In general, the hypermutated group had higher mutational frequencies in
  most genes in the affected pathways. One exception is the P53 mutation, a late-stage
  event in CRC carcinogenesis. The hypermutated group had low mutational frequency
  in P53, indicating that this group may have a carcinogenic mechanism distinct from
  the nonhypermutated group. A. WNT and TGF-β pathways. B. P53 pathway. C. PI3K and
  RTK-RAS pathways. Alteration frequencies are expressed as a percentage of all cases.
  HM: hypermutated group; nHM: nonhypermutated group.'
papertitle: The somatic POLE P286R mutation defines a unique subclass of colorectal
  cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.
reftext: Sung-Min Ahn, et al. Oncotarget. 2016 Oct 18;7(42):68638-68649.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.709914
figid_alias: PMC5356579__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5356579__F2
ndex: 77525f55-df31-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5356579__oncotarget-07-68638-g002.html
  '@type': Dataset
  description: 'In general, the hypermutated group had higher mutational frequencies
    in most genes in the affected pathways. One exception is the P53 mutation, a late-stage
    event in CRC carcinogenesis. The hypermutated group had low mutational frequency
    in P53, indicating that this group may have a carcinogenic mechanism distinct
    from the nonhypermutated group. A. WNT and TGF-β pathways. B. P53 pathway. C.
    PI3K and RTK-RAS pathways. Alteration frequencies are expressed as a percentage
    of all cases. HM: hypermutated group; nHM: nonhypermutated group.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - INHBA
  - INHBB
  - DKK4
  - DKK1
  - DKK2
  - DKK3
  - TGFBR1
  - TGFBR2
  - LRP5
  - ACVR2A
  - FZD10
  - APC
  - PROC
  - SMAD3
  - AXIN2
  - SMAD2
  - AMER1
  - SMAD4
  - CTNNB1
  - TCF7L2
  - FBXW7
  - ARID1A
  - SOX9
  - MYC
  - TCF7
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TP53
  - TP63
  - TP73
  - IGF2
  - ATM
  - ERBB3
  - ERBB2
  - IGF1R
  - IRS2
  - KRAS
  - NRAS
  - PTEN
  - BRAF
  - Cancer
  - Lung cancer
---
